Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Harmful pharmaceuticals found in world's rivers
Rivers included in the study included the Amazon, Mississippi, Thames and the Mekong.
Researchers measured the presence of metformin, caffeine and carbamazepine.

Pharmaceuticals at potentially toxic levels are present in more than 250 of the world’s rivers, according to research by the University of York.

The study published in Proceedings of the National Academy of Science (PNAS) looked at 258 rivers across the globe to measure the presence of 71 pharmaceuticals, including metformin, caffeine and carbamazepine.

It found that pharmaceutical pollution is contaminating water on every continent, with strong correlations between the socioeconomic status of a country and higher pollution of pharmaceuticals in its rivers.

The study also found that high levels of pharmaceutical pollution were most positively associated with regions of high median age, as well as local high unemployment and poverty rates.

Rubbish dumping along river banks, inadequate wastewater infrastructure and pharmaceutical manufacturing were cited as the activities most associated with the highest levels of pharmaceutical pollution. 

Project co-leader Dr John Wilkinson, from the University's department of environment and geography, described the study as an “excellent example of how the global scientific community can come together to tackle large-scale environmental issues”.

He added: "We’ve known for over two decades now that pharmaceuticals make their way into the aquatic environment where they may affect the biology of living organisms. But one of the largest problems we have faced in tackling this issue is that we have not been very representative when monitoring these contaminants, with almost all of the data focused on a select few areas in North America, Western Europe and China. 
 
"Through our project, our knowledge of the global distribution of pharmaceuticals in the aquatic environment has now been considerably enhanced. This one study presents data from more countries around the world than the entire scientific community was previously aware of 36 new countries to be precise where only 75 had ever been studied before." 
 
Researchers hope that through enhancing the monitoring of pharmaceuticals in the environment, they will be able to devise measures to restrict the consequences these contaminants may have. 

Rivers included in the study included the Amazon, Mississippi, Thames and the Mekong. 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.